Hesperos Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
IPO
- (Cancelled)
- Investors
-
8
Hesperos General Information
Description
Developer of human-on-a-chip systems designed to accelerate drug discovery. The company's technology utilizes interconnected multi-organ in vitro platforms and serum-free media, enabling pharmaceutical and cosmetic firms to determine the efficacy and toxicity of novel therapeutics without animal testing.
Contact Information
Website
www.hesperosinc.comCorporate Office
- 12501 Research Parkway
- Suite 100
- Orlando, FL 32826
- United States
Corporate Office
- 12501 Research Parkway
- Suite 100
- Orlando, FL 32826
- United States
Hesperos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. IPO | 13-Jul-2022 | Cancelled | Generating Revenue | |||
| 8. Later Stage VC | 28-Sep-2023 | Completed | Generating Revenue | |||
| 7. Debt - PPP | 11-Apr-2020 | Completed | Generating Revenue | |||
| 6. Grant | 26-Sep-2019 | Completed | Generating Revenue | |||
| 5. Grant | 06-Sep-2018 | Completed | Generating Revenue | |||
| 4. Grant | 09-Nov-2016 | Completed | Generating Revenue | |||
| 3. Grant | 02-Apr-2016 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Grant | 23-Nov-2015 | $690K | Completed | Generating Revenue |
Hesperos Comparisons
Industry
Financing
Details
Hesperos Competitors (31)
One of Hesperos’s 31 competitors is 28bio, a Venture Capital-Backed company based in New Orleans, LA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 28bio | Venture Capital-Backed | New Orleans, LA | ||||
| Thrive Bioscience | Venture Capital-Backed | Beverly, MA | ||||
| Emendo Biotherapeutics | Formerly VC-backed | Jersey City, NJ | ||||
| Aspect Biosystems | Venture Capital-Backed | Vancouver, Canada | ||||
| InSphero | Private Equity-Backed | Schlieren, Switzerland |
Hesperos Patents
Hesperos Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026050698-A1 | Method for prediction of drug-induced arrhythmogenicity during exercise-related cardiac stress | Pending | 29-Aug-2024 | ||
| US-11697795-B2 | Method and system for printing cells to a substrate comprising cell adhesive regions | Active | 07-Aug-2018 | ||
| US-20200048602-A1 | Method and system for printing cells to a substrate comprising cell adhesive regions | Active | 07-Aug-2018 | ||
| CA-3048884-A1 | Pumpless microfluidic organ-on-a-chip system including a functional immune system | Active | 30-Dec-2016 | ||
| EP-3562591-A1 | Pumpless microfluidic organ-on-a-chip system including a functional immune system | Pending | 30-Dec-2016 | B01L3/502753 |
Hesperos Signals
Hesperos Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Btomorrow Ventures | Corporate Venture Capital | Minority | ||
| National Center For Advancing Translational Sciences | Government | |||
| National Institute of Environmental Health Sciences | Government | |||
| National Institute on Aging | Government | |||
| National Institute of Mental Health | Government |
Hesperos FAQs
-
When was Hesperos founded?
Hesperos was founded in 2015.
-
Where is Hesperos headquartered?
Hesperos is headquartered in Orlando, FL.
-
What is the size of Hesperos?
Hesperos has 45 total employees.
-
What industry is Hesperos in?
Hesperos’s primary industry is Biotechnology.
-
Is Hesperos a private or public company?
Hesperos is a Private company.
-
What is Hesperos’s current revenue?
The current revenue for Hesperos is .
-
Who are Hesperos’s investors?
Btomorrow Ventures, National Center For Advancing Translational Sciences, National Institute of Environmental Health Sciences, National Institute on Aging, and National Institute of Mental Health are 5 of 8 investors who have invested in Hesperos.
-
Who are Hesperos’s competitors?
28bio, Thrive Bioscience, Emendo Biotherapeutics, Aspect Biosystems, and InSphero are some of the 31 competitors of Hesperos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process